Polyunsaturated fatty acids found in animals are fundamental products of successive desaturations and elongations of linoleic ( 18 : 2 , r i -6), a-holenic ( lX:3,ri -3), oleic ( 18 : 1 , r i -9) and palmitoleic ( 16 : 1 , t i -7) acids. The most important ones are those derived from linoleic and a-linolenic acids and they have major physiological implications.
Iri.srrliri
The first hormone studied was insulin. In 1966, we demonstrated that alloxan ( 1 10 mg/kg)-diabetic rats showed decreased A6-and A9-desaturase activities in liver. It was shown that A6-desaturation of linoleic, a-linolenic and oleic acids as well as A9-desaturation of palmitic and stearic acids werc depressed in diabetes and recovered after 48 h of insulin treatment ( 15 units of glucagon-free crystalline zinc insulin) [ I ] . There was no recovery if actinomycin D was injected before the insulin, indicating that protein synthesis is involved in the process.
Inhibition o f the A6-desaturasc modified the composition of microsomal fatty acids, indicating a decrease in arachidonic acid (20 : 4,ti -6 ) biosynthesis since the ratio 18 : 2,ri -6/20:4, ti -6 increased in the diabetic rat.
We also demonstrated that the AS-desaturase was inhibited in diabetic rats treated with streptozotocin (intravenous injection of 70 mg of streptozotocin/kg in citrate buffer, pH 4.5). The effect was not only shown in liver microsomes but also in adrenal gland microsomes and it was again corrected by insulin. Moreover. zona fasciculata reticularis cells o f the adrenals from diabetic rats were isolated and their capacity for AS-desaturation of 20:3,ri -6 was tested. It was shown that the activity was decreased and was partially restored after incubation of the cells with 1 munit o f insulin.
El Boustani er ul.
[ 21 have also shown that AS-desaturase activity is decreased in human type I diabetes iri vivo and is restored by insulin treatment.
Therefore, biosynthesis of arachidonic acid and, correspondingly. of oleic acid and polyunsaturated acids of the oleic and linoleic acid family, is decreased in diabetes and restored by insulin treatment.
Other metabolic hormones modify the A6-and AS-desaturation of fatty acids. Anti-insulin and glycogenolytic hormones inhibit the A6-desaturase.
Gliicugori
Glucagon, which enhances glycogenolysis through an increase in cyclic AMP, dccrcases A6-desaturase activity.
Abbreviations used: HTC. hcpatoma tissue culture; ACTH. adrenocorticotropic hormone.
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Glucagon was administered at a dose of 200 pg/8 h per 100 g body weight and dibutyryl cyclic AMP at a dose of S mg/X h per 100 g of body weight; both significantly decreased the A6-desaturation of linoleic and a-linolenic acids. Therefore, liver A6-desaturation of linoleic acid could be regulated by glucagon through its second messenger cyclic AMP and it is antagonistic to insulin.
A drer iulir i e
The results with glucagon prompted the investigation of another similar hyperglycaemic hormone, adrenaline. Different doses were investigated. Adrenaline, at 1 mg/kg body weight, evoked in the rat a rapid decrease in the A6-desaturation of linoleic acid in liver microsomes. After 90 min the effect was significant but the depression was the greatest after 12 h.
There was an increase in liver cyclic AMP levels 30 min after the administration of the hormone and this was followed immediately by breakdown of liver glycogen and an increase in plasma glucose. Therefore, the increase in cyclic AMP precedes the A6-desaturase decay which may be the direct consequence of cyclic AMP enhancement [ 31.
It was also shown that cyclic AMP inhibits A6-and A5-desaturases by incubating hepatoma tissue culture (HTC) cells with labelled a-linolenic acid in the presence of 10 Mdibutyryl cyclic AMP. The conversion of a-linolenic acid ( 18 : 3, ti -3) to eicosapentaenoic acid (20: 5 , r i -3) was decreased and the elongation product, eicosatrienoic acid (20: 3,ti -3), was increased.
Moreover, the effect of dibutyryl cyclic AMP o n the depression of AS-desaturation of dihomo-y-linolenic acid ( 2 0 : 3,ri -6 ) to arachidonic acid was found in liver microsomes, isolated liver cells and HTC cells.
It is known that adrenaline evokes an effect on adcnylatc cyclase through a P-adrenergic receptor. Propanolol and dichloroisoprotcrcnol are known P-blockers which block the glycogenolytic effect of adrenaline.
When these antagonists of adrenaline were injected 30 min earlier than adrenaline, they blocked its inhibitory effect on the A6-desaturation o f linoleic acid (18:2,n -6) to ylinolenic acid ( 18 : 3,ri -6). demonstrating that the effect of adrenaline on the desaturasc is produced through the activation of P-receptor. Isoprotcrenol, which is a B-adrencrgic agonist, evokes a similar effect to that of adrenaline by decreasing A6-dcsaturase activity.
Therefore, wc may deduce from these findings that the effect of adrenaline on the inhibition o f A6-and A5-dcsaturases is apparently evoked through P-receptors activating the adenylate cyclase system.
~;lii~,~)c(~rticoif~.s
Other hormones tested were the glucocorticoids. Injection of hydrocortisone (10 mg per rat) and the synthetic glucocorticoids, dexamethasone ( 1 mg per rat) and triamcynolone (2.5 mg per rat), produce. after 3 days of treatment, a decrease in the A6-desaturation of linoleic acid ( 18 : 2,ri -6 ) t o y-linolenic acid ( 18 : 3,ti -6 ) and in AS-desaturation of eicosatrienoic (20 : 3, ti -6) acid t o arachidonic acid (20:4,ri-6), while no decrease was observed in the A9-desaturation of palmitic acid 141.
The direct effect of dexamethasone on target cells was investigated by incubation of the drug with isolated hepatocytcs and HTC cells that have receptors for glucocorticoids. In both cases, a depression of the AS-desaturation of 20:3,ti-6 was observed after 6h of incubation with 0.1 and 0.2 mu-dexamethasone. The effect was already shown 2 h BIOCHEMICAL SOCIETY TRANSACTIONS after dexamethasone addition in HTC cells and 1 h in isolated hepatocytes and it decreased the 20 :4,n -6/ 20: 3,ti -6 ratio of the fatty acid composition of the cells.
The inhibitory effect of dexamethasone on the ASdesaturase activity in HTC cells was prevented by cycloheximide ( 10Yh M), demonstrating that protein synthesis is involved in the mechanism.
Therefore, dexamethasone would appear to induce the synthesis of a factor that modulates fatty acid desaturase activity. It was shown that both A6-and AS-desaturase activities were depressed by a factor present in the cytosolic fraction of cells. This factor is loosely bound to microsomes and can be extracted by a solution of low ionic strength and centrifugation at 110 000 gin the cold. It was found that only the cell supernatant from dexamethasone-treated animals inhibited the desaturation in control microsomes. The fact that the dexamethasone-induced factor is a protein was confirmed by trypsin inhibition.
From these results and considering the classical mechanism of glucocorticoid action, we may consider that these hormones penetrate the target cells reaching a nuclear receptor, which then activates the DNA to synthesize a messenger RNA for the expression of the protein factor. The mRNA would leave the nucleus and the protein factor is synthesized on the ribosomes subsequently inhibiting the A6-and ASdesaturases.
Other steroids
Since glucocorticoids inhibit the A6-and AS-desaturases, we investigated whether this effect was also evoked by other steroids by incubation with HTC cells.
The HTC cells were incubated for 3 h with the tested hormones at a concentration of 0.1 mM. Twenty minutes before the end of the incubation the IMEM-Zo medium was supplemented with 80 p~ labelled 20:3,n-6. Dexamethasone, a glucocorticoid, 1 1 -deoxycorticosterone a mineralocorticoid and 17-B-oestradiol, an oestrogen, were tested. All of them inhibited the AS-desaturation of 20: 3,n -6 and produced little effect on the incorporation of label into lipids, except for 1 1 -deoxycorticosterone which increased the incorporation.
These results prompted us to investigate other steroids and we could demonstrate that aldosterone, another mineralocorticoid hormone, inhibited the A5-desaturase, as did testosterone, corticosterone and oestradiol. However, progesterone, cortexolone, pregnanediol and other androgens were inactive. 1 1 -Deoxycorticosterone produced its effect through the induction of a soluble factor that inhibited the AS-desaturase similar to that found for glucocorticoids. Testosterone was also injected intraperitoneally into male and female rats (260 pglkg weight) and 24 h later the A9-, A6-and ASdesaturases were measured in liver microsomes. It was shown that the A9-desaturase was increased, whereas the A6-and AS-desaturases were decreased in both females and males.
This different response among the A%, A6-and A5-desaturases is repeatedly shown in endorcine/dietary manipulations and it demonstrated a different function of oleic and palmitoleic acids on one hand, and arachidonic and eicosapentenoic acids on the other.
The supernatant soluble fraction and cytosolic fraction from testosterone-treated rats did not decrease the A5-desaturase activity of microsomes, demonstrating that the mechanism of action of testosterone in the decrease in ASdesaturase activity is different from the mechanism of glucocorticoids and mineralocorticoids. It would appear not to be a genomic mechanism.
Testosterone administration produced a modification of the fatty acid composition of plasma lipids and microsomes after 24 h. It increased the 18:l,ri-9/18:0 ratio and decreased 20:4,t1-6/18:2,11-6 ratio. These results are in accordance with those changes observed in the desaturase activities.
Adrenocorticotropic hormone (A C'TH)
We have shown previously that adrenaline depresses, iri vivo, the microsomal A6-and AS-desaturases of liver and the same effect is shown in the adrenal glands. However, when adrenal glands were incubated directly with adrenaline, no effect was shown. This result suggests that adrenaline does not produce a direct effect on the gland. An indirect mechanism is evoked, possibly through ACTH release from the pituitary gland.
For this reason, we tested the effect of ACTH injection ( 3 i.u. per rat) 30 min before decapitation of the rats, on the microsomal A6-and AS-desaturase activities of liver and adrenal glands. An inhibitory effect of ACTH was found in both organs.
Depression of the AS-desaturase was also shown when isolated adrenal glands (zona fasciculata reticularis) and hepatocytes were incubated with 2.50 punits of ACTH for 3 h and the conversion of 20:3,r1-6 to 20:4,11-6 was measured IS]. That the inhibitory effect of ACTH may be produced through secondary corticoid production is very possible in adrenal glands, but the direct inhibition of liver desaturase activity demonstrated that the effect in this tissue is produced by ACTH per se.
The inhibitory effect of ACTH on 20: 3,n -6 desaturation was also found in isolated Sertoli cells and Leydig cells separated from testes of rats injected with ACTH (4.5 i.u. per rat). Thirty minutes after the intraperitoneal injection the rats were killed and cells were isolated.
The inhibitory effect of ACTH was also repeated when isolated Sertoli cells and Leydig cells were incubated with 250 p-i.u. of ACTH per flask. Dibutyryl cyclic AMP (0.5 mM) or corticosterone ( I pg per flask) also inhibited the reaction, suggesting that ACTH could produce a direct effect through cyclic AMP release, but it may also use corticosterone secretion in the whole animal.
From the results already discussed it is shown that, except for insulin which activates A6-and AS-desaturases in the diabetic animal, all the other hormones investigated depress the polyenoic desaturases, as is shown in Fig. I hitroriiicrioti A comprehensive treatise on the extent and type of modification which can be elicited by changes in the composition of diet, particularly the fatty acid composition, on the phospholipid fatty acid content o f mammalian cell membranes is beyond the scope of this brief, rather eclectic, perspective. For a more complete and detailed understanding readers are referred to a number of excellent reviews ([ 1-61 and thc other presentations in this Colloquium).
Essential fatty acids (EFA) are specific polyunsaturated fatty acids (PUFA) for which both man and animals have an obligatory dietary requirement. EFA deficiency results in physiological disorders and has been implicated in the aetiology of coronary vascular disease (CVD) [7-Y]. Three major familics o f PUFA occur in mammalian metabolism: ti -9, ti -6 and ti -3. Parent members of these distinct, non-interconvcrtible families of fatty acids are oleic acid ( 18: 1 ,ti -Y), linoleic acid ( 18 : 2, ii -6; LA) and a-linolenic acid ( 18 : 3, n -3). They can be metabolized in mammalian tissues by a series of desaturation and elongation reactions to yield longer-chain members of the respective families. Only members o f the n -6 and n -3 families are regarded as EFA; long-chain 11-9 PUFA cannot alleviate symptons of EFA deficiency. The 'true' EFA are the initial members of the ti -6 and ti -3 families, LA and a-linolenic acid; all others arc derived from them in sifii. The AY-, A6-, and ASdesaturases which catalyse the desaturations are membranebound extrinsic and immunological distinct proteins bound to the cytoplasmic surface of the endoplasmic reticular membranes by hydrophobic 'tails' [ 10, 1 11. The active complex consists of a short, membrane-bound electron-transport chain, flavoproteins (NADH-cytochrome h, reductase and NADPH-cytochrome 1'-450), cytochrome h, and the terminal dcsaturases 161; NADH or NADPH provide a source of electrons with molecular oxygen as the electron acceptor [6].
Long-chain PUFA derived from these desaturase reactions are primarily esterified in the sn-2 position of bilayer phospholipids of mammalian cell membranes. Incorporation of dietary PUFA, including EFA, into membrane phospholipids, withour prior modification by desaturases, also occurs. The extent to which specific EFA are incorporated into membrane phospholipids is determined by complex interactions, competitive and otherwise, between dietary Abbreviations used: EFA. essential fatty acids; PUFA, polyunsaturated fatty acids; CVD, cardiovascular diseases; LA, linoleic acid ( 1 8 : 2 , n -6 ) ; ARA, arachidonic acid (20:4,n-6); DHA, docosahexanoic acid(22:6,n-3) 18:l.n-9,OA; 18:3,n-3, LNA. fatty acids, other dietary factors (carbohydrates, proteins, trace elements, antioxidants) and endocrine changes [ 1-61. These interactions determine the extent to which dietary EFA are modified by the desaturases before being presented to the phospholipid : acyltransferases for incorporation into membrane phospholipid. The activity and substrate specificity of these transferases will also determine membrane phospholipid fatty acyl composition (I 121; Van EFA have two important roles in the regulation of cell function. The first is structural: EFA when incorporated into membrane phospholipids can alter the physiochemical characteristics (microviscosity or fluidity) of the membrane lipid matrix which in turn can influence the conformation, mobility and function of a wide variety of intrinsic and extrinsic membrane-bound proteins; these constitute the hormone receptors, ion gates and channels and boundenzymes ( [ 3 , 61; Stubbs & Smith, p. 77Y). Secondly, EFA of the n -6 and ti -3 families, dihomo-y-linolenic (20 : 3, n -6), arachidonic (20 : 4, n -6; ARA) and eicosapentaenoic (20: 5,n -3) acids, when released from their membrane phospholipid 'reservoirs' by phospholipase A2 or phospholipase C and diacyglycerol lipase, are transformed by cyclo-oxygenase to prostaglandins of series I, I1 and Ill, respectively. These EFA and certain other PUFA, including
